Bodkin Design Converts Military Defense Technology to Battle COVID-19

NEWTON, Mass., May 15, 2020 /PRNewswire/ — Bodkin Design & Engineering (BD&E), developers of sensor technology for the military, have turned their attention to defending the nation against the COVID-19 pandemic. They have just released a new instrument to aid in non-contact infrared thermometry, to spot individuals who are running a fever. The device, originally developed for the tracking cameras at the White Sands missile range, permits accurate thermal analysis from stand-off infrared sensors. This technology is now available as a low-cost solution for security checkpoints throughout the country.

In crowded public spaces, such as office buildings, factories, stores, meat-packing plants, airports, train stations and courthouses, it is important to remove individuals who might spread COVID-19. To determine who is infected, the primary method is to use non-contact infrared thermometry. One method uses infrared cameras to make thermal images of a populated scene. By placing BD&E’s temperature reference in the scene, it is possible to get an accurate temperature reading from a low-cost thermal camera. A simple comparison by the operator can easily spot fevered individuals.

BD&E’s Thermal Reference is now being evaluated by the US Army, who has a stockpile of thermal imagers used for night operations. These instruments can be converted to non-contact imaging thermometers by using the BD&E Thermal Reference. It is also being evaluated by the NYC Transit Authority for use in rail stations throughout the Metro region.

To learn more visit www.irblackbody.com. or http://www.bodkindesign.com.

About Bodkin Design & Engineering

Bodkin Design and Engineering, LLC has been providing concept development, prototype design/build, and engineering services to military, biotechnology, international OEM, and research communities since 2003. Headquartered in Newton, Massachusetts, BD&E holds contracts with the US Army, Air Force, Navy, Department of Homeland Security, National Aeronautic and Space Agency, and the Missile Defense Agency. BD&E has overseen the successful introduction of products ranging from miniature infrared UAV cameras to heavy equipment for railroad yards. The company produces a commercial line of calibration equipment for infrared imaging (IRblackbody.com), and a patented line of video rate hyperspectral imagers (hyperspectralimagers.com). To learn more, visit the website at www.bodkindesign.com.

CONTACT:
Mark Villafuerte
Bodkin Design & Engineering, LLC
77 Oak Street
Newton, MA 02462
Tel: 617.795.1968 x304
Fax: 617.795.1969
239905@email4pr.com 
www.bodkindesign.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/bodkin-design-converts-military-defense-technology-to-battle-covid-19-301059870.html

SOURCE Bodkin Design & Engineering, LLC

Staff

Recent Posts

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

39 minutes ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

39 minutes ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

16 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

16 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

16 hours ago